New regulator of liver metabolism discovered

September 29, 2017, Charité - Universitätsmedizin Berlin
Retinol saturase expressed (left). Retinol saturase depleted (right). (confocal microscopy, liver cells. Credit: M.Schupp

Researchers from Charité - Universitätsmedizin Berlin have identified an enzyme that has a major effect on glucose utilization in liver cells. The enzyme, retinol saturase, helps these cells adapt to variations in glucose levels. However, when glucose levels are consistently too high, retinol saturase appears to exert a damaging effect on cells. Results from this study have been published in the journal Nature Communications.

All can adapt their metabolic activity with respect to the availability of various sources of energy, such as glucose. This vital ability makes cells more efficient at absorbing and utilizing these substances, in addition to protecting them against the negative effects of overload. However, exposure to chronically-high glucose levels can result in an adaptive response which is damaging to cells and promoting diseases.

Led by Prof. Dr. Michael Schupp, head of the Molecular Pharmacology and Metabolism Working Group at Charité's Institute of Pharmacology, the researchers showed that the enzyme retinol saturase plays a role in the adaptive processes found in . By studying levels of the enzyme in both slim and obese participants, the researchers found that levels increase in line with body weight. They also analyzed the cells' metabolic pathways and their metabolic adaptation to glucose levels after reducing the enzyme's abundance. The negative metabolic effects associated with excess exposure to glucose were significantly less pronounced in cells that had been modified in this way.

Discussing the results of the study, Prof. Schupp concludes: "The inactivation of retinol saturase activity may offer a new approach to the treatment of metabolic liver disease and its associated problems, such as and dyslipidemia." As a next step, the researchers are planning to identify the mechanisms involved, and to test whether other cell types also need the enzyme to adapt to changing .

Explore further: Food withdrawal results in stabilization of important tumor suppressor

More information: Steffi Heidenreich et al, Retinol saturase coordinates liver metabolism by regulating ChREBP activity, Nature Communications (2017). DOI: 10.1038/s41467-017-00430-w

Related Stories

Food withdrawal results in stabilization of important tumor suppressor

December 21, 2016
Tumor suppressors stop healthy cells from becoming cancerous. Researchers from Charité - Universitätsmedizin Berlin, the Medical University of Graz and the German Institute of Human Nutrition in Potsdam-Rehbruecke have ...

Metabolism can be used to subtype hepatoblastoma tumors

September 18, 2017
Looking at cell metabolism instead of histology, EPFL scientists have identified new biomarkers that could help more accurately classify the two main subtypes of hepatoblastoma, a children liver cancer.

Enzyme produced in the liver promotes obesity, fatty liver disease and insulin resistance

August 25, 2017
In mice that are fed a high-fat diet, an increased production of the enzyme DPP4 by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance. These were the findings of a study ...

Too much sugar? There's an enzyme for that

January 11, 2016
Guilt-free sugary treats may be on the horizon. Scientists at the University of Montreal Hospital Research Centre (CRCHUM) have discovered an enzyme that can stop the toxic effects of sugar in various organs of the body. ...

Fat degrading enzyme implicated in type 2 diabetes

January 18, 2017
Investigators at Karolinska Institutet have identified a potential therapeutic target for treatment of obesity-associated metabolic diseases such as type 2 diabetes and nonalcoholic hepatic steatosis. The work, performed ...

Recommended for you

Team provides insight into glucagon's role in diabetic heart disease

February 21, 2018
A UT Southwestern study reveals the hormone glucagon's importance to the development of insulin resistance and cardiac dysfunction during Type 2 diabetes, presenting opportunities to develop new therapies for diabetic diseases ...

Physical exercise reduces risk of developing diabetes: study

February 20, 2018
Exercising more reduces the risk of diabetes and could see seven million fewer diabetic patients across mainland China, Hong Kong and Taiwan, according to new research.

Some viruses produce insulin-like hormones that can stimulate human cells—and have potential to cause disease

February 19, 2018
Every cell in your body responds to the hormone insulin, and if that process starts to fail, you get diabetes. In an unexpected finding, scientists at Joslin Diabetes Center have identified four viruses that can produce insulin-like ...

Researchers discover link between gut and type 1 diabetes

February 19, 2018
Scientists have found that targeting micro-organisms in the gut, known as microbiota, could have the potential to help prevent type 1 diabetes.

Researchers find existing drug effective at preventing onset of type 1 diabetes

February 15, 2018
A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz ...

Chemist designs diabetic treatment minus harmful side effects

February 9, 2018
A chemist in the College of Arts and Sciences (A&S) has figured out how to control glucose levels in the bloodstream without the usual side effects of nausea, vomiting or malaise.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.